From: Evaluation of anaplastic thyroid carcinoma in the Kurdistan region of Iraq
Mean | Median1` | ||||||||
---|---|---|---|---|---|---|---|---|---|
95% Confidence Interval | 95% Confidence Interval | P* | |||||||
Estimate | SE | Lower Bound | Estimate | SE | Lower Bound | Upper Bound | |||
Grading | |||||||||
A | 7.42 | 2.17 | 3.17 | 11.68 | 7.00 | 1.30 | 4.43 | 9.56 | |
B | 3.71 | 1.30 | 1.15 | 6.27 | 2.00 | 0.43 | 1.14 | 2.85 | |
C | 5.50 | 2.64 | 0.32 | 10.67 | 2.00 | 1.83 | 0.00 | 5.60 | 0.441 |
Size | |||||||||
≤ 4 cm | 1.50 | 0.28 | 0.93 | 2.06 | 1.00 | ||||
> 4 cm | 6.56 | 1.36 | 3.89 | 9.22 | 5.00 | 2.00 | 1.08 | 8.92 | 0.006 |
WBCs | |||||||||
< 10,000 | 6.84 | 1.60 | 3.69 | 9.99 | 5.00 | 2.39 | 0.30 | 9.69 | |
≥ 10,000 | 3.14 | 1.20 | 0.78 | 5.50 | 2.00 | 0.39 | 1.21 | 2.78 | 0.104 |
Intervention | |||||||||
Operable | 7.41 | 1.73 | 4.00 | 10.82 | 7.00 | 2.30 | 2.47 | 11.52 | |
Non-operable | 2.75 | 0.64 | 1.48 | 4.02 | 2.00 | 0.45 | 1.10 | 2.89 | 0.015 |
Type of therapy | |||||||||
Chemotherapy | 3.500 | 2.500 | 0.000 | 8.400 | 1.000 | ||||
Radio-therapy | 2.000 | 0.000 | 2.000 | 2.000 | 2.000 | ||||
Surgery | 3.250 | 1.797 | 0.000 | 6.772 | 1.000 | 2.000 | 0.000 | 4.920 | |
Chemo and radio | 3.000 | 0.707 | 1.614 | 4.386 | 2.000 | ||||
Multiple modality | 9.500 | 7.500 | 0.000 | 24.200 | 2.000 | ||||
Sympto-matic treatment | 1.000 | 0.000 | 1.000 | 1.000 | 1.000 | ||||
Radio surgery therapy | 9.500 | 2.187 | 5.213 | 13.787 | 8.000 | 1.225 | 5.600 | 10.400 | 0.063 |
Overall | 5.550 | 1.178 | 3.242 | 7.858 | 3.000 | 1.491 | 0.078 | 5.922 |